Collectively, this points to a likely role for IL-17 in BDD pathogenesis and may offer treatment options, given IL-17 is a promising target for human psoriasis therapeutics (Krueger et al., 2012; Leonardi et al., 2012). Here, IL17A is linked to psoriasis.